berotralstat dihydrochloride

berotralstat dihydrochloride (ORLADEYO) is an FDA-listed pharmaceutical active ingredient. Associated with Biocryst. Route of administration: oral. Current US regulatory status: approved.

ORLADEYO is a marketed brand name for berotralstat dihydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

berotralstat dihydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.